CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Angiotensin–neprilysin inhibition versus enalapril in heart failure Right ventricular function and outcome in patients undergoing transcatheter aortic valve replacement Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association Management of Asymptomatic Severe Aortic Stenosis: Evolving Concepts in Timing of Valve Replacement Impact of Severe Sarcopenia on Rehospitalization and Survival One Year After a TAVR Procedure in Patients Aged 75 and Older Potential Mechanisms of In-stent Neointimal Atherosclerotic Plaque Formation Non-obstructive High-Risk Plaques Increase the Risk of Future Culprit Lesions Comparable to Obstructive Plaques Without High-Risk Features: The ICONIC Study Tissue characterisation of atherosclerotic plaque in the left main: an in vivo intravascular ultrasound radiofrequency data analysis

Clinical Trial2014 Sep 11;371(11):993-1004.

JOURNAL:N Engl J Med. Article Link

Angiotensin–neprilysin inhibition versus enalapril in heart failure

McMurray JJ, Packer M, PARADIGM-HF Investigators and Committees. Keywords: angiotensin receptor-neprilysin inhibitor LCZ696; enalapril; HFrEF; mortality; survival; hospitalization for heart failure

FULL TEXT PDF